Exosomes as nanocarriers for siRNA delivery: paradigms and challenges

被引:45
|
作者
Shahabipour, Fahimeh [1 ,2 ]
Banach, Maciej [3 ]
Sahebkar, Amirhossein [4 ]
机构
[1] Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran
[2] Mashhad Univ Med Sci, Dept Med Biotechnol, Neurogen Inflammat Res Ctr, Mashhad, Iran
[3] Med Univ Lodz, Dept Hypertens, Chair Nephrol & Hypertens, Lodz, Poland
[4] Mashhad Univ Med Sci, Biotechnol Res Ctr, Vakilabad Blvd, Mashhad 9177948564, Iran
关键词
exosome; siRNA; microRNA; nanomedicine; drug delivery; gene therapy; MIMETIC NANOVESICLES; IN-VITRO; RNA; CELLS; CHEMOTHERAPEUTICS; VACCINE;
D O I
10.5114/aoms.2016.62911
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exosomes are nano-sized vesicles that facilitate intercellular communications through carrying genetic materials and functional biomolecules. Owing to their unique size and structure, exosomes have emerged as a useful tool to overcome the limitations of siRNA delivery. The use of exosomes as siRNA delivery vehicles lacks certain disadvantages of the existing foreign delivery systems such as viruses, polycationic polymers and liposomes, and introduces several advantages including inherent capacity to pass through biological barriers and escape from phagocytosis by the reticuloendothelial system, as well as being biocompatible, non-toxic, and immunologically inert. Different strategies have been employed to harness exosome-based delivery systems, including surface modification with targeting ligands, and using exosome-display technology, virus-modified exosomes, and exosome-mimetic vesicles. The present review provides a capsule summary of the recent advances and current challenges in the field of exosome-mediated siRNA delivery.
引用
收藏
页码:1324 / 1326
页数:3
相关论文
共 50 条
  • [31] Non-viral nanocarriers for siRNA delivery in breast cancer
    Zhang, Jing
    Li, Xiang
    Huang, Leaf
    JOURNAL OF CONTROLLED RELEASE, 2014, 190 : 440 - 450
  • [32] Modularized Gold Nanocarriers for TAT-Mediated Delivery of siRNA
    Huang, Xiao
    Lai, Yifan
    Braun, Gary B.
    Reich, Norbert O.
    SMALL, 2017, 13 (08)
  • [33] Using exosomes, naturally-equipped nanocarriers, for drug delivery
    Batrakova, Elena V.
    Kim, Myung Soo
    JOURNAL OF CONTROLLED RELEASE, 2015, 219 : 396 - 405
  • [34] Glycerol Monooleate-Based Nanocarriers for siRNA Delivery in Vitro
    Zhen, Guoliang
    Hinton, Tracey M.
    Muir, Benjamin W.
    Shi, Shuning
    Tizard, Mark
    McLean, Keith M.
    Hartley, Patrick G.
    Gunatillake, Pathiraja
    MOLECULAR PHARMACEUTICS, 2012, 9 (09) : 2450 - 2457
  • [35] Nanocarriers for siRNA Delivery Aimed at the Treatment of Melanoma: Systematic Review
    de Araujo, Brenda Regina
    do Nascimento, Tatielle
    dos Santos Matos, Ana Paula
    de Souza Belmiro, Vanessa Brandao
    de Bustamante Monteiro, Mariana Sato de Souza
    Santos-Oliveira, Ralph
    Ricci-Junior, Eduardo
    CURRENT DRUG DELIVERY, 2023,
  • [36] Non-viral nanocarriers for siRNA delivery in breast cancer
    Zhang, Jing
    Li, Xiang
    Huang, Leaf
    Journal of Controlled Release, 2014, 190 : 440 - 450
  • [37] Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain
    Yuan, Dongfen
    Zhao, Yuling
    Banks, William A.
    Bullock, Kristin M.
    Haney, Matthew
    Batrakova, Elena
    Kabanov, Alexander V.
    BIOMATERIALS, 2017, 142 : 1 - 12
  • [38] The challenges of oral drug delivery via nanocarriers
    Reinholz, Jonas
    Landfester, Katharina
    Mailaender, Volker
    DRUG DELIVERY, 2018, 25 (01) : 1694 - 1705
  • [39] Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies
    Kumar, Mahesh
    Virmani, Tarun
    Kumar, Girish
    Deshmukh, Rohitas
    Sharma, Ashwani
    Duarte, Sofia
    Brandao, Pedro
    Fonte, Pedro
    PHARMACEUTICALS, 2023, 16 (10)
  • [40] Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System
    Oliveira, Ana C. N.
    Fernandes, Joana
    Goncalves, Anabela
    Gomes, Andreia C.
    Real Oliveira, M. E. C. D.
    CURRENT DRUG TARGETS, 2019, 20 (01) : 29 - 50